Bosh sahifaPSTV • NASDAQ
add
Plus Therapeutics Inc
Yopilish kursi
1,28 $
Kunlik diapazon
1,23 $ - 1,28 $
Yillik diapazon
1,12 $ - 2,67 $
Bozor kapitalizatsiyasi
6,85 mln USD
Oʻrtacha hajm
98,39 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 1,46 mln | 17,42% |
Joriy xarajat | 2,40 mln | 19,97% |
Sof foyda | -2,87 mln | 10,72% |
Sof foyda marjasi | -197,39 | 23,96% |
Har bir ulushga tushum | -0,37 | 63,00% |
EBITDA | -3,60 mln | -16,43% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 4,79 mln | -56,50% |
Jami aktivlari | 6,98 mln | -47,45% |
Jami passivlari | 12,15 mln | 14,04% |
Umumiy kapital | -5,17 mln | — |
Tarqatilgan aksiyalar | 5,90 mln | — |
Narxi/balansdagi bahosi | -1,45 | — |
Aktivlardan daromad | -104,43% | — |
Kapitaldan daromad | 318,44% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -2,87 mln | 10,72% |
Operatsiyalardan naqd pul | -3,68 mln | -53,40% |
Sarmoyadan naqd pul | -9,00 ming | 10,00% |
Moliyadan naqd pul | 0,00 | -100,00% |
Naqd pulning sof oʻzgarishi | -3,69 mln | -3 423,42% |
Boʻsh pul | -8,35 mln | -525,46% |
Haqida
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, United States. Wikipedia
Tashkil etilgan
1996
Xodimlar soni
20